Jennison Associates’s EPIRUS BIOPHARMACEUTICALS INC COM EPRS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2016
Q2
Sell
-2,613,159
Closed -$7.03M 678
2016
Q1
$7.03M Buy
2,613,159
+15,291
+0.6% +$41.1K 0.01% 471
2015
Q4
$8.03M Buy
2,597,868
+3,912
+0.2% +$12.1K 0.01% 488
2015
Q3
$11.5M Sell
2,593,956
-36,986
-1% -$163K 0.01% 492
2015
Q2
$15M Buy
2,630,942
+15,948
+0.6% +$91.1K 0.01% 480
2015
Q1
$23.4M Buy
+2,614,994
New +$23.4M 0.02% 427
2014
Q4
Sell
-12,436
Closed -$89K 796
2014
Q3
$89K Buy
+12,436
New +$89K ﹤0.01% 712